{
  "name": "Mg-meds.GitHub.io",
  "tagline": "",
  "body": "# IMPACT OF MEDICATIONS ON MYASTHENIA GRAVIS PATIENT POPULATION AT UNIVERSITY HOSPITAL\r\n## REFRENCES\r\n\r\nCarr, Aisling S., et al. \"A systematic review of population based epidemiological studies in Myasthenia Gravis.\" BMC neurology 10.1 (2010): 1.\r\n\r\nConti-Fine, Bianca M., Monica Milani, and Henry J. Kaminski. \"Myasthenia gravis: past, present, and future.\" The Journal of clinical investigation 116.11 (2006): 2843-2854.\r\n\r\nDrachman, B. and Amato A. Myasthenia Gravis Image. AccessMedicine, McGraw-Hill Medical. http://accessmedicine.mhmedical.com/MultimediaPlayer.aspx?MultimediaID=12986892&SearchTerm=myasthenia%20gravis\r\n\r\n[\"Drugs to Avoid.\"](http://www.myasthenia.org/LivingwithMG/DrugstoAvoid.aspx) Myasthenia Gravis Foundation of America, INC. Myasthenia Gravis Foundation of America, INC., n.d. Web. 22 Aug. 2016.http://www.myasthenia.org/LivingwithMG/DrugstoAvoid.aspx\r\n\r\nMeriggioli, Matthew N., and Donald B. Sanders. \"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.\" The Lancet Neurology 8.5 (2009): 475-490.",
  "note": "Don't delete this file! It's used internally to help with page regeneration."
}